ABBIO
Board
2 directors, last change in 2022E.C.A. BV
Director, permanent representative Jacques Vanreck
since 01-07-2022
term without a fixed end
also on the board of 5 other companies
listed in the 2025 annual accounts, filed on 31-07-2026
Director
since 24-10-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 31-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 11. Pouvoirs de l'organe d'administration S'il n'y a qu'un seul administrateur, la totalité des pouvoirs d'administration lui est…”deed of 16-07-2020
Permanent representatives 1
Mandates through the years
4 names, the dashed line is todayE.C.A.
Director
Director
Amara Soltani
Director
Director
André Burckel
Manager (not named in the articles)
Manager (not named in the articles)
Vanreck Jacques Oscar Jules Ghislain
Manager (not named in the articles)
Manager (not named in the articles)
BoardEarlier
Mandates as a list
- E.C.A.
- Director, from 02-01-2017 to date
- Amara Soltani
- Director, from 24-10-2022 to date
- André Burckel
- Manager (not named in the articles), appointed by deed of 16-07-2020, until 24-10-2022
- Vanreck Jacques Oscar Jules Ghislain
- Manager (not named in the articles), from 02-01-2017 to 01-07-2022
Control
100%
This company
ABBIO
Equity -€87,859
Loss €97,527 in 2025
Capital
- Contribution
- €20,000
- Source
- 2025 annual accounts
Articles of association
deed of 16-07-2020 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of June
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 16-07-2020 ↗
- MEDICLARO all shares
Capital over time
- 16-07-2020 Converted to unavailable equity